Literature DB >> 8686741

Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection.

D Schlaifer1, S Krajewski, S Galoin, F Rigal-Huguet, G Laurent, P Massip, J Pris, G Delsol, J C Reed, P Brousset.   

Abstract

The expression of the apoptosis-regulating genes Bcl-2, Bcl-x, Bax, Mcl-1, and p53 analyzed in 4 cases of human immunodeficiency virus (HIV)-associated Hodgkin's disease, in 36 cases of HIV-related non-Hodgkin's lymphomas (NHLs), and in 109 cases of non-HIV-related NHLs by using immunohistochemistry. HIV-associated Hodgkin's disease samples were positive for all markers. For the HIV-related NHL samples, 36, 66, 88, 100, and 94% of the cases were Bcl-2, Bcl-x, Bax, Mcl-1, and p53 were found to be expressed in 69, 65, 82, 83, and 42%, respectively. No significant differences were observed in Bax and Mcl-1 staining between HIV-unrelated NHLs of B cell and T cell types. In contrast, Bcl-2 was positive in 66/79 (83%) and 10/30 (33%) of B cell and T cell HIV-unrelated NHLs, respectively (P2 < 0.001). Peculiar patterns were observed for hairy cell leukemia (Bax+, Bcl-2+, Mcl-1-) and for anaplastic large cell lymphoma (Bax+, Mcl-1+, Bcl-2-) in HIV-unrelated NHLs. Of interest, all cases with a positive expression of Bax were also found to express either Mcl-1 and/or Bcl-2, suggesting that Mcl-1 and Bcl-2 may counteract the pro-apoptosis function of Bax in vivo by protein-protein interaction within the tumor cell, as demonstrated previously in vitro. These results suggest that apoptosis regulation may have a role in the pathogenesis of some HIV-related and HIV-unrelated NHLs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8686741      PMCID: PMC1865215     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Down-regulation of bcl-2 by p53 in breast cancer cells.

Authors:  S Haldar; M Negrini; M Monne; S Sabbioni; C M Croce
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

Review 2.  p53 in hematologic malignancies.

Authors:  J Imamura; I Miyoshi; H P Koeffler
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

Review 3.  Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages.

Authors:  M Prokocimer; V Rotter
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

Review 4.  Molecular regulation of apoptosis: genetic controls on cell death.

Authors:  G T Williams; C A Smith
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

5.  Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas.

Authors:  H Nakamura; J W Said; C W Miller; H P Koeffler
Journal:  Blood       Date:  1993-08-01       Impact factor: 22.113

6.  Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.

Authors:  S Krajewski; S Bodrug; R Gascoyne; K Berean; M Krajewska; J C Reed
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

7.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

8.  Immunohistochemical analysis of in vivo patterns of Bcl-X expression.

Authors:  S Krajewski; M Krajewska; A Shabaik; H G Wang; S Irie; L Fong; J C Reed
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

Review 10.  Bcl-2 and the regulation of programmed cell death.

Authors:  J C Reed
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more
  6 in total

1.  Bcl-2 expression in anaplastic large cell lymphoma.

Authors:  C Villalva; F Bougrine; G Delsol; P Brousset
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

2.  High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma.

Authors:  R Rust; G Harms; T Blokzijl; M Boot; A Diepstra; J Kluiver; L Visser; S-C Peh; M Lim; W A Kamps; S Poppema; A van den Berg
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

Review 3.  Histopathological evaluation of apoptosis in cancer.

Authors:  Y Soini; P Pääkkö; V P Lehto
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

4.  A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.

Authors:  Chun Chao; Michael J Silverberg; Lanfang Xu; Lie-Hong Chen; Brandon Castor; Otoniel Martínez-Maza; Donald I Abrams; Hongbin D Zha; Reina Haque; Jonathan Said
Journal:  Clin Cancer Res       Date:  2015-01-14       Impact factor: 12.531

5.  Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.

Authors:  G Z Rassidakis; A H Sarris; M Herling; R J Ford; F Cabanillas; T J McDonnell; L J Medeiros
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  MicroRNA-21 inhibits mitochondria-mediated apoptosis in keloid.

Authors:  Hao Wu; Jie Wang; Hui Ma; Zhibo Xiao; Xiaoqun Dong
Journal:  Oncotarget       Date:  2017-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.